A Newly Synthetized Ferrocenyl Derivative Selectively Induces Apoptosis in ALL Lymphocytes through Mitochondrial

Marjan Aghvami1, Jalal Pourahmad1, Afshin Zarghi1

  • 1Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abstract

Insights

A novel ferrocenyl derivative selectively induces cancer cell death in Acute Lymphoblastic Leukemia (ALL) by targeting mitochondrial estrogen receptors. This compound initiates apoptosis, offering a potential new therapeutic strategy for this challenging pediatric malignancy.

Area of Science:

  • Endocrinology
  • Cancer Biology
  • Pharmacology

Background:

  • Estrogens, primarily female steroid hormones, influence reproductive and non-reproductive systems.
  • Estrogen receptors (ERα and ERβ) expression in B-cell malignancies and on mitochondria suggests a role in cancerous lymphocyte lifespan.
  • Acute Lymphoblastic Leukemia (ALL), a common pediatric malignancy, is often recurrent and difficult to treat due to apoptosis-resistant malignant cells.

Purpose of the Study:

  • To investigate the cytotoxic effects of a new ferrocenyl derivative compared to raloxifene (a SERM) on cancerous lymphocytes.
  • To evaluate the impact of these compounds on mitochondrial function, apoptosis, and lymphocyte survival.

Main Methods:

  • Mitochondria were targeted as the cell's life/death center.
  • Cytotoxicity of a novel ferrocenyl derivative and raloxifene was compared.
  • Apoptotic processes and cancerous lymphocyte survival were assessed.

Main Results:

  • Both the ferrocenyl derivative and raloxifene induced mitochondrial damage.
  • Apoptosis was initiated via caspase activation and cytochrome c release.
  • The ferrocenyl derivative demonstrated estrogen-related selective apoptosis in cancerous lymphocytes.

Conclusions:

  • The ferrocenyl derivative selectively induces apoptosis in cancerous lymphocytes by interacting with mitochondrial estrogen receptors.
  • This compound shows potential as a therapeutic agent for Acute Lymphoblastic Leukemia by targeting cancer cell mitochondria.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.8K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.7K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.7K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
15.4K